(Q73145906)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066040%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066040%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

B Thiesen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066040%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

B Greenwood

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066040%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

N Brieske

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066040%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Achtman

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066040%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 February 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066040%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066040%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066040%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066040%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

209-219

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066040%20AND%20SRC:MED&resulttype=core&format=json

Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

The efficacy of meningococcal polysaccharide vaccine in preventing group A meningococcal disease in The Gambia, West Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Antibody Responses of Human Infants to Three Doses of Group A Neisseria meningitidis Polysaccharide Vaccine Administered at Two, Four, and Six Months of Age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Immunogenicity of group A and group C meningococcal polysaccharides in human infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Antibody response to meningococcal polysaccharides A and C in patients with complement defects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Duration of antibody responses after vaccination with group C Neisseria meningitidis polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Kinetics of Antibody Production to Group A and Group C Meningococcal Polysaccharide Vaccines Administered during the First Six Years of Life: Prospects for Routine Immunization of Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

The duration of the antibody response to meningococcal vaccination in an African village

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Meningococcal carriage, meningococcal disease and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in The Gambia, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Immunogenicity and evolutionary variability of epitopes within IgA1 protease from serogroup A Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Variation in class 5 protein expression by serogroup A meningococci during a meningitis epidemic.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Antibodies against IgA1 protease are stimulated both by clinical disease and asymptomatic carriage of serogroup A Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Human monoclonal antibodies against an epitope on the class 5c outer membrane protein common to many pathogenic strains of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Elisa for Human IgG and IpM Anti-Lipopolysaccharide Antibodies with Indirect Standardization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Gene structure and extracellular secretion of Neisseria gonorrhoeae IgA protease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Standard sera in solid-phase immunoassays

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Determination of parallelism and nonparallelism in bioassay dilution curves.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Quantitative Determination of the Human Immune Response to Immunization with Meningococcal Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Persistence of measles antibody in the absence of circulating natural virus five years after immunization of an isolated virgin population with Edmonston B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Further-attenuated measles vaccine: characteristics and use.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Persistence of antibody at 18 months following vaccination of young Gambian infants with PRP-OMPC Haemophilus influenzae type b conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titres following primary and booster doses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Serological evaluation of a simplified immunization schedule using quadruple DPT-polio vaccine in Burkina Faso

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

Carriage of Haemophilus influenzae in healthy Gambian children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900138-7

7 January 2021

10.1016/S0264-410X(96)00138-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066040%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference